Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 348

1.

Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence.

Golden-Mason L, Burton JR Jr, Castelblanco N, Klarquist J, Benlloch S, Wang C, Rosen HR.

Hepatology. 2006 Nov;44(5):1098-109.

PMID:
17058243
2.

Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.

Bengsch B, Spangenberg HC, Kersting N, Neumann-Haefelin C, Panther E, von Weizsäcker F, Blum HE, Pircher H, Thimme R.

J Virol. 2007 Jan;81(2):945-53. Epub 2006 Nov 1.

3.

Distributional characteristics of CD25 and CD127 on CD4+ T cell subsets in chronic HCV infection.

Shen T, Chen X, Xu Q, Lu F, Liu S.

Arch Virol. 2010 May;155(5):627-34. doi: 10.1007/s00705-010-0626-z. Epub 2010 Mar 5.

PMID:
20204427
4.

Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.

Urbani S, Amadei B, Fisicaro P, Tola D, Orlandini A, Sacchelli L, Mori C, Missale G, Ferrari C.

Hepatology. 2006 Jul;44(1):126-39.

PMID:
16799989
6.

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.

Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H, Rehermann B.

J Immunol. 2002 Sep 15;169(6):3447-58.

7.

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.

Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ, Chisari FV.

Hepatology. 2001 Jan;33(1):267-76.

PMID:
11124845
8.

FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.

Heeg MH, Ulsenheimer A, Grüner NH, Zachoval R, Jung MC, Gerlach JT, Raziorrouh B, Schraut W, Horster S, Kauke T, Spannagl M, Diepolder HM.

Gastroenterology. 2009 Oct;137(4):1280-8.e1-6. doi: 10.1053/j.gastro.2009.06.059. Epub 2009 Jul 29.

PMID:
19596013
9.

IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection.

Vranjkovic A, Crawley AM, Patey A, Angel JB.

J Leukoc Biol. 2011 Apr;89(4):499-506. doi: 10.1189/jlb.0710430. Epub 2010 Dec 21.

PMID:
21177484
10.

Progressive CD127 down-regulation correlates with increased apoptosis of CD8 T cells during chronic HIV-1 infection.

Zhang SY, Zhang Z, Fu JL, Kang FB, Xu XS, Nie WM, Zhou CB, Zhao M, Wang FS.

Eur J Immunol. 2009 May;39(5):1425-34. doi: 10.1002/eji.200839059.

11.

Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.

Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Carreño V.

J Med Virol. 2006 Sep;78(9):1190-7.

PMID:
16847959
12.

Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.

Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, Bouwer HG, Hinrichs DJ.

Hepatology. 2002 Jan;35(1):190-8.

PMID:
11786976
13.

Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cells.

Crawley AM, Vranjkovic A, Young C, Angel JB.

Eur J Immunol. 2010 May;40(5):1396-407. doi: 10.1002/eji.200940093.

14.
15.

Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection.

Smyk-Pearson S, Golden-Mason L, Klarquist J, Burton JR Jr, Tester IA, Wang CC, Culbertson N, Vandenbark AA, Rosen HR.

J Infect Dis. 2008 Jan 1;197(1):46-57. doi: 10.1086/523651.

PMID:
18171284
16.

Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection.

Aberle JH, Formann E, Steindl-Munda P, Weseslindtner L, Gurguta C, Perstinger G, Grilnberger E, Laferl H, Dienes HP, Popow-Kraupp T, Ferenci P, Holzmann H.

J Clin Virol. 2006 May;36(1):24-31. Epub 2006 Feb 17.

PMID:
16483838
17.

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, Nelson DR.

Hepatology. 2004 Nov;40(5):1062-71.

PMID:
15486925
18.

In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.

Krishnadas DK, Li W, Kumar R, Tyrrell LJ, Agrawal B.

Cell Immunol. 2009;259(2):141-9. doi: 10.1016/j.cellimm.2009.06.009. Epub 2009 Jun 23.

PMID:
19616202
19.

Long-term follow-up after successful interferon therapy of acute hepatitis C.

Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H.

Hepatology. 2004 Jul;40(1):98-107.

PMID:
15239091
20.

Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection.

Lancaster T, Sanders E, Christie JM, Brooks C, Green S, Rosenberg WM.

J Viral Hepat. 2002 Jan;9(1):18-28.

PMID:
11851899

Supplemental Content

Support Center